Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-011574
Filing Date
2015-02-10
Accepted
2015-02-10 18:10:01
Documents
2
Period of Report
2015-01-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1527
2 EX-24 DOCUMENT attachment1.htm EX-24 3301
  Complete submission text file 0001209191-15-011574.txt   6219
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Issuer) CIK: 0001269021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ONYX PHARMACEUTICALS, INC. 2100 POWELL STREET EMERYVILLE CA 94608
Business Address
Brege Laura (Reporting) CIK: 0001365619 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35935 | Film No.: 15595416